Showing 1 posts of 1 posts found.
Boehringer Ingelheim will kick off its pharma investments in 2016 with a half a billion Euro outlay and plans to …
Long-acting therapies set to reshape HIV treatment market
MHRA authorises Lynkuet for hot flushes linked to breast cancer therapy
MHRA approves Romvimza for tenosynovial giant cell tumour
NICE recommends allergy immunotherapy tablets for younger children
Dunbar Pharmaceuticals and IPS Pharma announce distribution agreement